About Contact


Canadian contract research organization (CRO) Dalriada specializes in small-molecule drug therapies. As an agile and co-located integrated drug discovery partner, Dalriada accelerates the discovery and development of high-value, small-molecule therapeutics from concept to investigational new drug (IND).

Dalriada is named for Dal Riata, an early Middle Age Gaelic kingdom whose expanse comprises parts of modern Scotland and Northern Ireland. We created a visual identity honouring this history — and the heritage of a company founder — then applied it to a logomark befitting molecular science. Three D’s with an embedded molecule symbolize Gaelic art while communicating company offerings of discovery strategy, discovery management, and discovery laboratories.

Plain-language key brand messages simplify an involved turnkey drug discovery process.

Our Services


The equation that led to Dalriada's icon.

The old brand and the new brand.

The new Dalriada Icon and Wordmark.

The new Dalriada Icon.

The Dalriada brand standards.

The Dalriada business cards.

The Dalriada business cards close up.

The Dalriada letterhead.

Examples of new Dalriada illustrations.

Examples of new Dalriada icons.

A new Dalriada white coat.

A new Dalriada white coat close up.

A Dalriada poster.

A Dalriada backlit poster.
Convinced? Contact Us Need More Proof? View More Projects

Subscribe To Our Lab Report

Carter Hales Design Lab Inc. will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at studio@carterhales.com. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.